Moderate riskFDA DrugClass II

Pemetrexed for Injection recalled for lack of sterility assurance

Reliance Life Sciences Private Limited is recalling Pemetrexed for Injection 500 mg/vial, manufactured for Somerset Therapeutics, LLC, for lack of sterility assurance. The recall covers four lots, 5,020 vials in total, distributed nationwide in the USA. No injuries have been reported.

From the FDA notice · Read the official notice ↗

What to do

  1. Set aside any vials from lots RPTH0125A, RPTH0225A, RPTH0325A (expiry Jan 31, 2028), or RPTH0725A (expiry Apr 30, 2028), and do not administer them.
  2. Check the NDC 70069-0835-01 on the carton and the lot number and expiry date on the vial to confirm whether a product is affected.
  3. The notice doesn't say how to return or replace affected vials; contact Somerset Therapeutics, LLC or Reliance Life Sciences Private Limited for instructions.

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01
Sold in
Nationwide
Made for
All ages (0 months and older)

This recall covers 4 products — see all of them.

Details

Units affected
5,020 vials
Illnesses reported
None reported
Manufactured in
Ttc Area Of Midc, R - 282 Dhirubhai Ambani Life Sciences Centre; Thane Belapur Road, Navi Mumbai, N/A, India
Classification
Class II
Recall number
D-0672-2026

In the FDA's words

Description
Pemetrexed for Injection 500mg/Vial, 1 50 mL Single-Dose Vial per carton, For intravenous use only, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873 NDC: 70069-0835-01 Lack of Sterility Assurance Lot, expiry: RPTH0125A Jan 31, 2028; RPTH0225A Jan 31, 2028; RPTH0325A Jan 31, 2028; RPTH0725A Apr 30, 2028; Distribution: Nationwide in the USA Affected quantity: 5,020 vials
Hazard
Lack of Sterility Assurance

4 products in this recall

Somerset Therapeutics cancer drug vials recalled for lack of sterility

Reliance Life Sciences is recalling four injectable cancer drugs made for Somerset Therapeutics: Pemetrexed for Injection 100 mg and 500 mg vials, Bortezomib for Injection 3.5 mg vials, and Azacitidine for Injection 100 mg vials. The recall covers about 36,000 vials nationwide because of a lack of sterility assurance. No injuries have been reported.

The agency lists each product separately. Check every one you might have.

Related topics

SterilityDrugsSold nationwideMore from FDA Drug